Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE0006632003
Fri, 12.07.2024       MorphoSys AG
DE0006632003

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014 Key word(s): Squeeze Out Planegg/Munich, Germany, July 12, 2024   Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00   MorphoSys AG (FSE: MOR; NASDAQ: MOR) announces that Novartis BidCo Germany AG submitted a specified re [ … ]
Technical analysis Trade The News (TTN)
To the publication
Thu, 20.06.2024       MorphoSys AG
DE0006632003

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014 Key word(s): Squeeze Out Planegg/Munich, Germany, June 20, 2024     Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders MorphoSys AG (FSE: MOR; NASDAQ: MOR) announces that Nov [ … ]
Technical analysis Trade The News (TTN)
To the publication
Thu, 20.06.2024       MorphoSys AG
DE0006632003

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014 Key word(s): Squeeze Out Planegg/Munich, Germany, June 20, 2024     Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders MorphoSys AG (FSE: MOR; NASDAQ: MOR) announces that Nov [ … ]
Technical analysis Trade The News (TTN)
To the publication
Thu, 06.06.2024       MorphoSys AG
DE0006632003

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014   Planegg/Munich, Germany, June 6, 2024     Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO   Following the closing of the takeover offer by Novartis BidCo AG to th [ … ]
Technical analysis Trade The News (TTN)
To the publication
Mon, 05.02.2024       MorphoSys AG
DE0006632003

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014   Planegg/Munich, Germany, February 5, 2024     Ad hoc: MorphoSys AG Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value and into Purchase Agreement with Incyte for the Sale of Tafasitamab M [ … ]
Technical analysis Trade The News (TTN)
To the publication
Tue, 30.01.2024       MorphoSys AG
DE0006632003

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014 Planegg/Munich, Germany, January 30, 2024   Ad hoc: MorphoSys AG Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability Preliminary 2023 Monjuvi U.S. net pro [ … ]
Technical analysis Trade The News (TTN)
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 23.12.2024, Calendar Week 52, 358th day of the year, 8 days remaining until EoY.